within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03F_ProgestogensAndEstrogensInCombination.G03FA01_NorethisteroneAndEstroge;

model NorethisteroneAndEstroge
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.5,
    Cl = 1.6666666666666667e-05,
    adminDuration = 600,
    adminMass = 1 / 1000000,
    adminCount = 1,
    Vd = 0.004,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.016666666666666666,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>NorethisteroneAndEstrogen</td></tr><tr><td>ATC code:</td><td>G03FA01</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>1</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>4</td><td>L</td></tr>
    <tr><td>clearance:</td><td>60</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Norethisterone and estrogen are combined hormonal preparations used for hormone replacement therapy (HRT) in postmenopausal women and previously also in contraception. Norethisterone is a synthetic progestogen, while estrogen in such combinations is commonly estradiol or ethinylestradiol. These combinations alleviate menopausal symptoms and prevent osteoporosis. Such combined HRT regimens are approved and used in many countries today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult women after oral administration, based on typical literature values for norethisterone and estradiol or ethinylestradiol separately, as no published studies provide a combined PK model for the combination product.</p><h4>References</h4><ol><li><p>Vose, CW, et al., &amp; Serlin, MJ (1979). Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate. <i>Contraception</i> 19(2) 119–127. DOI:<a href=\"https://doi.org/10.1016/s0010-7824(79)80024-4\">10.1016/s0010-7824(79)80024-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/428229/\">https://pubmed.ncbi.nlm.nih.gov/428229</a></p></li><li><p>Goldzieher, JW (1990). Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications. <i>American journal of obstetrics and gynecology</i> 163(1 Pt 2) 318–322. DOI:<a href=\"https://doi.org/10.1016/0002-9378(90)90575-r\">10.1016/0002-9378(90)90575-r</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2196804/\">https://pubmed.ncbi.nlm.nih.gov/2196804</a></p></li><li><p>Garza-Flores, J, et al., &amp; Perez-Palacios, G (1991). Long-acting hormonal contraceptives for women. <i>The Journal of steroid biochemistry and molecular biology</i> 40(4-6) 697–704. DOI:<a href=\"https://doi.org/10.1016/0960-0760(91)90293-e\">10.1016/0960-0760(91)90293-e</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1958567/\">https://pubmed.ncbi.nlm.nih.gov/1958567</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G03FA01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end NorethisteroneAndEstroge;
